PARP inhibitor era in ovarian cancer treatment: a systematic review and meta-analysis of randomized controlled trials

被引：0
|
作者：
István Baradács
Brigitta Teutsch
Alex Váradi
Alexandra Bilá
Ádám Vincze
Péter Hegyi
Tamás Fazekas
Balázs Komoróczy
Péter Nyirády
Nándor Ács
Ferenc Bánhidy
Balázs Lintner
机构：
[1] Semmelweis University,Department of Obstetrics and Gynecology
[2] Semmelweis University,Centre for Translational Medicine
[3] University of Pécs,Institute for Translational Medicine, Szentágothai Research Centre, Medical School
[4] Semmelweis University,Division of Pancreatic Diseases, Heart and Vascular Center
[5] Semmelweis University,Department of Urology
[6] Semmelweis University,School of Medicine
来源：
Journal of Ovarian Research | / 17卷
关键词：
Olaparib; Niraparib; Rucaparib; HRD; Homologous recombination repair;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] PARP inhibitor era in ovarian cancer treatment: a systematic review and meta-analysis of randomized controlled trials
    Baradacs, Istvan
    Teutsch, Brigitta
    Varadi, Alex
    Bila, Alexandra
    Vincze, Adam
    Hegyi, Peter
    Fazekas, Tamas
    Komoroczy, Balazs
    Nyirady, Peter
    Acs, Nandor
    Banhidy, Ferenc
    Lintner, Balazs
    JOURNAL OF OVARIAN RESEARCH, 2024, 17 (01)
  • [2] Efficacy and Safety of PARP Inhibitor Therapy in Advanced Ovarian Cancer: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials
    Chen, Juying
    Wu, Xiaozhe
    Wang, Hongzhe
    Lian, Xiaoshan
    Li, Bing
    Zhan, Xiangbo
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2024, 20 (06) : 736 - 751
  • [3] Efficacy and safety of PARP inhibitors in the treatment of advanced ovarian cancer: An updated systematic review and meta-analysis of randomized controlled trials
    Hao, Jiatao
    Liu, Ying
    Zhang, Taohong
    He, Jinmei
    Zhao, Haoyi
    An, Ruifang
    Xue, Yan
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 157
  • [4] Angiogenesis Inhibitors for the Treatment of Ovarian Cancer: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials
    Wang, Haihong
    Xu, Tie
    Zheng, Lifen
    Li, Guiling
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (05) : 903 - 914
  • [5] Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis
    Mills, E
    Wu, P
    Seely, D
    Guyatt, G
    JOURNAL OF PINEAL RESEARCH, 2005, 39 (04) : 360 - 366
  • [6] The Era of PARP inhibitors in ovarian cancer: "Class Action" or not? A systematic review and meta-analysis
    Staropoli, Nicoletta
    Ciliberto, Domenico
    Del Giudice, Teresa
    Iuliano, Eleonora
    Cuce, Maria
    Grillone, Francesco
    Salvino, Angela
    Barbieri, Vito
    Russo, Antonio
    Tassone, Pierfrancesco
    Tagliaferri, Pierosandro
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 131 : 83 - 89
  • [7] Efficacy and safety of PARP inhibitor maintenance therapy for ovarian cancer: a meta-analysis and trial sequential analysis of randomized controlled trials
    Sun, Guojuan
    Liu, Yi
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [8] Efficacy and safety of PARP inhibitors combined with antiangiogenic agents in the maintenance treatment of ovarian cancer: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials
    Wei, Yan
    He, Li
    Liu, Tao
    Guo, Tao
    Xie, Cong
    Jia, Jigang
    Lin, Yonghong
    Liu, Jiang
    Fan, Jiayin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [9] Role of targeted therapy in ovarian cancer treatment: a systematic review and meta-analysis of randomized trials
    Staropoli, N.
    Ciliberto, D.
    Chiellino, S.
    Del Giudice, T.
    Caglioti, F.
    Strangio, A.
    Salvino, A.
    Tassone, P.
    Tagliaferri, P.
    ANNALS OF ONCOLOGY, 2015, 26 : 34 - 34
  • [10] Kuntai capsule for the treatment of diminished ovarian reserve: A systematic review and meta-analysis of randomized controlled trials
    Zhang, Xudong
    Zhang, Lina
    Xiong, Ling
    Liu, Xia
    Zhang, Juwen
    Yu, Fanya
    Li, Yun
    Chang, Wenjing
    Chen, Wei
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 329
12345